Illumina asks court to halt BGI’s sequencer distribution
Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.
Irish nutrition group faces Kaneka patent suit
Japanese drugmaker Kaneka has accused Irish nutrition company Glanbia of infringing two patents with its ActiQuinol antioxidant products.
3M drops IBM healthcare software suit
US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Health campaigners call for greater checks on AbbVie/Allergan merger
Trade unions and consumer groups have urged the Federal Trade Commission to intervene in the planned $63 billion merger of drugmakers AbbVie and Allergan, arguing it would “substantially harm competition”.
Sanofi partners with HHS to work on COVID-19 vaccine
Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.
Eli Lilly claims another victory in Taltz patent battle
The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.
Ex-Sandoz exec pleads guilty to price fixing in generics probe
Hector Armando Kellum, a former senior executive at Novartis division Sandoz, has pleaded guilty to his role in a conspiracy to fix prices for generic drugs, the US Department of Justice announced.
Indian drugmaker joins race to find COVID-19 vaccine
Indian drugmaker Zydus Cadila has launched a fast track programme to develop a vaccine for the novel coronavirus COVID-19, which has so far claimed more than 1,600 lives worldwide.
J&J, HHS sign expanded deal to find COVID-19 vaccine
Johnson & Johnson unit Janssen has expanded an existing R&D agreement with the US Department of Health and Human Services (HHS) as part of efforts to speed up the development of an investigational vaccine for the novel coronavirus COVID-19.
10x Genomics strikes back in Bio-Rad saga with USITC ban
US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.
